PRA Health Sciences (PRAH) Tops Q3 EPS by 3c; Updates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PRA Health Sciences, Inc. Reports Third Quarter 2017 Results and Updates Full Year 2017 Guidance
October 25, 2017 4:00 PM EDTNet new business of $598.5 million; Net book-to-bill of 1.26$494.6 million of service revenue; 23.7% actual growth and 18.9% organic growth at actual foreign exchange rates and 23.0% growth and 18.2% organic growth on a constant currency basisGAAP Net Income per diluted share was $0.73 and GAAP Net Income was $48.2 millionAdjusted Net Income per diluted share was $0.88 per share and Adjusted Net Income was $57.9 millionUpdating full year 2017 service revenue guidance to between $1.914 billion and $1.926 billion, GAAP net income per diluted share to between $2.31 and $2.38, and Adjusted Net Income per... More
